Year |
Citation |
Score |
2019 |
Sharma S, Sharma RK, Gaur K, Cátala Torres JF, Loza-Rosas SA, Torres A, Saxena M, Julin M, Tinoco AD. Fueling a Hot Debate on the Application of TiO Nanoparticles in Sunscreen. Materials (Basel, Switzerland). 12. PMID 31330764 DOI: 10.3390/Ma12142317 |
0.633 |
|
2018 |
Saxena M, Loza-Rosas SA, Gaur K, Sharma S, Pérez Otero SC, Tinoco AD. Exploring titanium(IV) chemical proximity to iron(III) to elucidate a function for Ti(IV) in the human body. Coordination Chemistry Reviews. 363: 109-125. PMID 30270932 DOI: 10.1016/J.Ccr.2018.03.006 |
0.666 |
|
2018 |
Saxena M, Delgado Y, Sharma RK, Sharma S, Guzmán SLPL, Tinoco AD, Griebenow K. Inducing cell death in vitro in cancer cells by targeted delivery of cytochrome c via a transferrin conjugate. Plos One. 13: e0195542. PMID 29649293 DOI: 10.1371/Journal.Pone.0195542 |
0.666 |
|
2016 |
Tinoco AD, Saxena M, Sharma S, Noinaj N, Delgado Y, Quiñones González EP, Conklin SE, Zambrana N, Loza-Rosas SA, Parks TB. The unusual synergism of transferrin and citrate in the regulation of Ti(IV) speciation, transport, and toxicity. Journal of the American Chemical Society. PMID 27070073 DOI: 10.1021/Jacs.6B01966 |
0.695 |
|
2016 |
Tinoco AD, Loza-Rosas SA, Vazquez A, Rivero KI, Negron LM, Saxena M, Sharma S, Delgado Y, Sanchez A, Zambrana N, Parks TB. Abstract 3105A: Titanium(IV) regulation by serum transferrin and citrate sheds new insight into the use of chemical transferrin mimetics for Ti(IV) anticancer drug development Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-3105A |
0.711 |
|
Show low-probability matches. |